Connection
Christine Walsh to Drug Administration Schedule
This is a "connection" page, showing publications Christine Walsh has written about Drug Administration Schedule.
|
|
Connection Strength |
|
 |
|
 |
|
0.158 |
|
|
|
-
Walsh CS, Kamrava M, Rogatko A, Kim S, Li A, Cass I, Karlan B, Rimel BJ. Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer. PLoS One. 2021; 16(6):e0252665.
Score: 0.158